↑ Rising
Business
AstraZeneca, Ionis report major trial failure with heart disease drug
AstraZeneca and Ionis share prices plunge following the failure of a key clinical trial for the heart disease drug Wainua.
1 trends tracked about this subject — the full history, oldest to newest below.
AstraZeneca and Ionis share prices plunge following the failure of a key clinical trial for the heart disease drug Wainua.